Skip to main content
BRAIN Biotech AG logo

BRAIN Biotech AG — Investor Relations & Filings

Ticker · BNN ISIN · DE0005203947 LEI · 391200JKPVHLD6JLZ107 F Professional, scientific and technical activities
Filings indexed 370 across all filing types
Latest filing 2016-02-03 Capital/Financing Update
Country DE Germany
Listing F BNN

About BRAIN Biotech AG

https://www.brain-biotech.com/

BRAIN Biotech AG is an industrial biotechnology company specializing in the discovery, development, and production of specialty enzymes, high-performance microorganisms, and bioactive compounds. The company provides tailor-made biosolutions and contract research and development (R&D) services to partners in the food, chemical, and life sciences sectors. Core competencies include enzyme technology, microbial strain development, and bioprocess development. By leveraging an advanced technology portfolio, which includes proprietary platforms for enzyme discovery and genome editing, the company enables its partners to create more sustainable and efficient industrial products and processes, contributing to the bioeconomy.

Recent filings

Filing Released Lang Actions
B.R.A.I.N. Biotechnology Research And Information Network AG: BRAIN AG sets IPO price at 9 Euros per share
Capital/Financing Update Classification · 98% confidence The document is an 'Ad-hoc' release dated February 3, 2016, announcing that BRAIN AG has set its Initial Public Offering (IPO) price at 9 Euros per share and that the offering is accomplished. This announcement details the placement volume, capital increase, shareholder structure changes post-IPO, and planned admission to the Frankfurt Stock Exchange. This clearly relates to fundraising, financing activities, and capital structure changes associated with going public. This aligns best with the 'Capital/Financing Update' category (CAP). It is not a full 10-K, an earnings release (ER), or a general regulatory filing (RNS), as it describes a specific corporate financing event.
2016-02-03 English
Jahresabschluss zum Geschäftsjahr vom 01.10.2014 bis zum 30.09.2015
Annual Report Classification · 100% confidence The document is a 'Jahresabschluss' (Annual Financial Statement) and 'Lagebericht' (Management Report) for B.R.A.I.N. AG for the fiscal year 2014/2015. It contains detailed financial performance analysis, management commentary, and operational results. While it is a German document, it functions as the primary annual reporting document for the company, which corresponds to the 10-K category in the provided schema. FY 2015
2016-01-25 German
BRAIN AG sets IPO price range
Share Issue/Capital Change Classification · 99% confidence The document is a press release dated January 20, 2016, announcing that BRAIN AG has set the price range for its Initial Public Offering (IPO). Key phrases include "BRAIN AG sets IPO price range," details about the price range (9.00 to 12.00 Euros), the subscription period, and the intended listing on the Frankfurt Stock Exchange. This content directly relates to fundraising, capital structure changes, and the issuance of new securities, which aligns perfectly with the definition of 'Capital/Financing Update' (CAP). Although it mentions the prospectus is published, the primary focus is the announcement of the financing terms, not the report itself, making CAP more specific than RPA or RNS.
2016-01-20 English
BRAIN AG announces Intention to Float
Share Issue/Capital Change Classification · 99% confidence The document is a press release titled "BRAIN AG announces Intention to Float" and explicitly mentions preparing for an "Initial Public Offering ("IPO" or "the Offer") in the Regulated Market (Prime Standard) of the Frankfurt Stock Exchange." This announcement details the company's business model, growth strategy, financial performance leading up to the event, and the intended use of the IPO proceeds. This content directly relates to fundraising and capital structure changes, fitting the definition of a Capital/Financing Update (CAP). It is not a full annual report (10-K), an earnings release (ER), or a general regulatory filing (RNS), as it is specifically about the IPO process.
2016-01-05 English
Datum:22.10.2015
Management Reports Classification · 100% confidence The document is a 'Lagebericht' (Management Report) for the fiscal year 2013/2014 for B.R.A.I.N. AG. It contains detailed sections on the business model, research and development, economic environment, business performance, financial position, and investments. This is a comprehensive management discussion and analysis of the company's financial results and business outlook, which aligns perfectly with the definition of a Management Report (MDA).
2015-10-22 German
Datum:07.01.2015
Annual Report Classification · 95% confidence The document is a 'Lagebericht' (Management Report) for B.R.A.I.N. AG for the fiscal year 2012/2013. It contains detailed financial analysis, balance sheet data, risk reports, and operational performance metrics. In German corporate reporting, the 'Jahresabschluss' (Annual Financial Statements) and 'Lagebericht' (Management Report) together constitute the core of the Annual Report. Since this document provides the comprehensive financial and operational narrative for the full fiscal year, it is classified as an Annual Report (10-K). FY 2013
2015-01-07 German

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.